Cargando…
Screening for novel protein targets of indomethacin in HCT116 human colon cancer cells using proteomics
Non-steroidal anti-inflammatory drugs, such as indomethacin (IN), inhibit colorectal cancer (CRC) growth through cyclooxygenase (COX)-independent mechanisms, however, the precise biological mechanisms are not completely understood. The aim of the present study was to investigate new molecular factor...
Autores principales: | CHENG, YAN-LI, ZHANG, GUI-YING, LI, CUI, LIN, JING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813814/ https://www.ncbi.nlm.nih.gov/pubmed/24179499 http://dx.doi.org/10.3892/ol.2013.1560 |
Ejemplares similares
-
In situ Proteomic Profiling of Curcumin Targets in HCT116 Colon Cancer Cell Line
por: Wang, Jigang, et al.
Publicado: (2016) -
Intra-Tumoral Heterogeneity in Metastatic Potential and Survival Signaling between Iso-Clonal HCT116 and HCT116b Human Colon Carcinoma Cell Lines
por: Chowdhury, Sanjib, et al.
Publicado: (2013) -
Crosstalk among proteome, acetylome and succinylome in colon cancer HCT116 cell treated with sodium dichloroacetate
por: Zhu, Danxi, et al.
Publicado: (2016) -
Proteins that interact with calgranulin B in the human colon cancer cell line HCT-116
por: Myung, Jae Kyung, et al.
Publicado: (2016) -
Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells
por: Sabit, Hussein, et al.
Publicado: (2016)